预购协议遭单方面终止,三叶草生物被要求退还2.24亿美元

新京报
25 Mar

三叶草生物与全球疫苗免疫联盟之间的预购协议发生了重大变动。3月24日,三叶草生物发布公告,全资附属子公司三叶草生物制药(香港)有限公司(以下简称“三叶草香港”)收到全球疫苗免疫联盟(GAVI)的书面通知,称其单方面终止预购协议,并要求三叶草香港退还预付款项2.24亿美元。自上市至2024年上半年,三叶草生物已累计亏损超87亿元,市值仅0.5亿美元,这笔退款无疑将让其承受巨大资金压力。三叶草生物拒绝...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10